{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:12:42Z","timestamp":1793610762804,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171234"],"award-info":[{"award-number":["32171234"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870844"],"award-info":[{"award-number":["31870844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874080"],"award-info":[{"award-number":["81874080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbadis.2025.167876","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:21:22Z","timestamp":1745763682000},"page":"167876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cisplatin reduces immunosuppression caused by tumor-associated macrophages through downregulating CD47-SIRP\u03b1 signaling in glioblastoma"],"prefix":"10.1016","volume":"1871","author":[{"given":"Yanyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lize","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167876_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2025.167876_bb0015","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbadis.2025.167876_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100715","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbadis.2025.167876_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-007-9483-3","article-title":"A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)","volume":"86","author":"Swinnen","year":"2008","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2004.11.019","article-title":"First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia","volume":"22","author":"Brandes","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0040","article-title":"Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbadis.2025.167876_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106556","article-title":"Induction of immunogenic cell death by novel platinum-based anticancer agents","volume":"187","author":"Chang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2025.167876_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167876_bb0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2025.167876_bb0060","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41388-019-1045-6","article-title":"MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/\u03b2-catenin signaling pathway","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.167876_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216605","article-title":"AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy","volume":"583","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2025.167876_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004589","article-title":"CD47\/SIRP\u03b1 axis: bridging innate and adaptive immunity","volume":"10","author":"van Duijn","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2025.167876_bb0075","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167876_bb0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2023.10.035","article-title":"SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer","volume":"682","author":"Wang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.167876_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167876_bb0095","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167876_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2025.167876_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-019-1166-3","article-title":"Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src\/CD155\/MIF functional pathway","volume":"38","author":"Huang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167876_bb0110","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.167876_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.seminoncol.2020.05.009","article-title":"Just eat it: a review of CD47 and SIRP-\u03b1 antagonism","volume":"47","author":"Oronsky","year":"2020","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0120","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.molcel.2022.06.030","article-title":"Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma","volume":"82","author":"Torrini","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167876_bb0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10985549.2023.2253131","article-title":"Mitochondrial fragmentation promotes inflammation resolution responses in macrophages via histone lactylation","volume":"43","author":"Susser","year":"2023","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0130","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167876_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12943-023-01856-1","article-title":"CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2025.167876_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13059-022-02775-y","article-title":"H3K18 lactylation marks tissue-specific active enhancers","volume":"23","author":"Galle","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2025.167876_bb0145","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3892\/ol.2015.2931","article-title":"Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma","volume":"9","author":"Feng","year":"2015","journal-title":"Oncol. Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:47:41Z","timestamp":1750283261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0925443925002248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167876","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisplatin reduces immunosuppression caused by tumor-associated macrophages through downregulating CD47-SIRP\u03b1 signaling in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167876"}}